These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10975874)

  • 1. Cyclosporin A protects striatal neurons in vitro and in vivo from 3-nitropropionic acid toxicity.
    Leventhal L; Sortwell CE; Hanbury R; Collier TJ; Kordower JH; Palfi S
    J Comp Neurol; 2000 Oct; 425(4):471-8. PubMed ID: 10975874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astrocytes from cortex and striatum show differential responses to mitochondrial toxin and BDNF: implications for protection of striatal neurons expressing mutant huntingtin.
    Saba J; López Couselo F; Turati J; Carniglia L; Durand D; de Laurentiis A; Lasaga M; Caruso C
    J Neuroinflammation; 2020 Oct; 17(1):290. PubMed ID: 33023623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The differential vulnerability of striatal projection neurons in 3-nitropropionic acid-treated rats does not match that typical of adult-onset Huntington's disease.
    Sun Z; Xie J; Reiner A
    Exp Neurol; 2002 Jul; 176(1):55-65. PubMed ID: 12093082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats.
    Escartin C; Boyer F; Bemelmans AP; Hantraye P; Brouillet E
    Neurosci Lett; 2007 Oct; 425(3):167-72. PubMed ID: 17868993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease.
    Ramaswamy S; McBride JL; Herzog CD; Brandon E; Gasmi M; Bartus RT; Kordower JH
    Neurobiol Dis; 2007 May; 26(2):375-84. PubMed ID: 17336076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonists.
    Blum D; Galas MC; Pintor A; Brouillet E; Ledent C; Muller CE; Bantubungi K; Galluzzo M; Gall D; Cuvelier L; Rolland AS; Popoli P; Schiffmann SN
    J Neurosci; 2003 Jun; 23(12):5361-9. PubMed ID: 12832562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alpha-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid.
    Nakao N; Brundin P
    Neuroscience; 1997 Feb; 76(3):749-61. PubMed ID: 9135048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the mechanisms of neuroprotection by creatine and phosphocreatine.
    Brustovetsky N; Brustovetsky T; Dubinsky JM
    J Neurochem; 2001 Jan; 76(2):425-34. PubMed ID: 11208905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bradykinin receptor agonist facilitates low-dose cyclosporine-A protection against 6-hydroxydopamine neurotoxicity.
    Borlongan CV; Emerich DF; Hoffer BJ; Bartus RT
    Brain Res; 2002 Nov; 956(2):211-20. PubMed ID: 12445688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic intoxication with 3-nitropropionic acid in rats induces the loss of striatal dopamine terminals without affecting nigral cell viability.
    Blum D; Galas MC; Cuvelier L; Schiffmann SN
    Neurosci Lett; 2004 Jan; 354(3):234-8. PubMed ID: 14700739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity.
    Blum D; Gall D; Galas MC; d'Alcantara P; Bantubungi K; Schiffmann SN
    J Neurosci; 2002 Oct; 22(20):9122-33. PubMed ID: 12388620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Death of cortical and striatal neurons induced by mitochondrial defect involves differential molecular mechanisms.
    Galas MC; Bizat N; Cuvelier L; Bantubungi K; Brouillet E; Schiffmann SN; Blum D
    Neurobiol Dis; 2004 Feb; 15(1):152-9. PubMed ID: 14751780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An adenoviral vector expressing the glucose transporter protects cultured striatal neurons from 3-nitropropionic acid.
    Fink SL; Ho DY; McLaughlin J; Sapolsky RM
    Brain Res; 2000 Mar; 859(1):21-5. PubMed ID: 10720611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF.
    McBride JL; During MJ; Wuu J; Chen EY; Leurgans SE; Kordower JH
    Exp Neurol; 2003 Jun; 181(2):213-23. PubMed ID: 12781994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Nitropropionic acid exacerbates N-methyl-D-aspartate toxicity in striatal culture by multiple mechanisms.
    Greene JG; Sheu SS; Gross RA; Greenamyre JT
    Neuroscience; 1998 May; 84(2):503-10. PubMed ID: 9539220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topological analysis of striatal lesions induced by 3-nitropropionic acid in the Lewis rat.
    Blum D; Gall D; Cuvelier L; Schiffmann SN
    Neuroreport; 2001 Jun; 12(8):1769-72. PubMed ID: 11409756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minocycline in phenotypic models of Huntington's disease.
    Bantubungi K; Jacquard C; Greco A; Pintor A; Chtarto A; Tai K; Galas MC; Tenenbaum L; Déglon N; Popoli P; Minghetti L; Brouillet E; Brotchi J; Levivier M; Schiffmann SN; Blum D
    Neurobiol Dis; 2005 Feb; 18(1):206-17. PubMed ID: 15649711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memantine reduces striatal cell death with decreasing calpain level in 3-nitropropionic model of Huntington's disease.
    Lee ST; Chu K; Park JE; Kang L; Ko SY; Jung KH; Kim M
    Brain Res; 2006 Nov; 1118(1):199-207. PubMed ID: 16959224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-methyl-D-aspartate receptor antagonists have variable affect in 3-nitropropionic acid toxicity.
    Nasr P; Carbery T; Geddes JW
    Neurochem Res; 2009 Mar; 34(3):490-8. PubMed ID: 18688711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease.
    Lee ST; Park JE; Kim DH; Kim S; Im WS; Kang L; Jung SH; Kim MW; Chu K; Kim M
    Brain Res; 2008 Feb; 1194():130-7. PubMed ID: 18166168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.